Andrew Thomas

Andrew obtained his bachelor’s in Biology from Mackenzie University and was an intern at the Institute of Psychiatry investigating genetic polymorphisms associated with Alzheimer’s and Parkinson’s disease. For his Master’s in Oncology dissertation, obtained from AC Camargo Cancer Centre, he investigated the effects of alcohol and tobacco consumption on the oral microbiota. He obtained his PhD in Bioinformatics from the University of Sao Paulo. During his academic training, he has worked on several projects that included: "Studies of microbial diversity in the Zoological Park of the State of São Paulo (University of Sao Paulo)”, "Effects of short-chain fatty acids produced by probiotic bacteria in the prophylaxis and treatment of allergic airway inflammation” (Federal University of Sao Paulo) and “Identifying reproducible gut microbial signatures to detect colorectal cancer” (University of Trento). Currently, he is part of the Horizon 2020 funded project ”Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response”, where he supports project partners with computational analyses of gut microbiomes from several different cancer types. His current role in Seerave is to help in the analysis of the gut microbiome and response to immunotherapy in the PRIMM cohorts (King’s College London, University of Groningen and University of Trento).